Letters In Print
Re-audit of bedside glucose monitoring of inpatients on glucocorticoids – have we improved?
Bawden D, Baral R, Gaur S, Rogers R, Dhatariya K.
British Journal of Diabetes 2021;21(1):156-157
Reply to: Incidence of thyroid disease in patients with forefoot deformity.
Dhatariya K, Loveday D.
Foot and Ankle Surgery. 2021;27(1):116
Institutional factors in the management of adults with diabetic ketoacidosis in the UK: results of a national survey.
Nunney I, Iceton G.
Diabetic Medicine 2016;33(2):269-270
Comment on Erondu et al. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program.
Diabetes Care 2015;38:1680–1686
Determining the utility of the 60 min cortisol measurement in the short synacthen test.
Clinical Endocrinology 2014;80(5):767-768
Reply to: Limitations to using point of care blood ketone testing to monitor DKA treatment.
Pract Diab 2013;30:381-382
Response to Taylor. Insulin dose requirement in diabetic ketoacidosis.
Savage M W, Kilvert A, Courtney H, Hammersley M, Rees A, Rayman G.
Archives of Internal Medicine. 2008;168:13:1470
Dehydroepiandrosterone has not been substantiated as an anabolic hormone.
Diabetic Medicine 2012; 29(1):153-154
Home blood glucose testing.
Mayo Clinic Proceeding 2007; 82(5):638-639
Policing of information from internet breast cancer list: Findings may not be generally applicable
BMJ 2006;332:1095
DHEA levels in treated Cushing’s Disease may contribute to low quality of life
Clinical Endocrinology 2005;62(2):258-259
Aspirin for everyone over 50?: Don’t forget aspirin resistance.
BMJ 2005;331:161